Clinical trials

Active, not recruiting clinical trials

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Phase: 2
Disease: Alopecia Universalis (AU), Alopecia Totalis (AT)
Location(s): United States, New York
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Phase: 2
Disease: alopecia areata
Location(s):
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.
A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

Phase: 2
Disease: vitiligo
Location(s):
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

Phase: 2
Disease: Androgenetic Alopecia
Location(s): Colorado, Oregon, Texas
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Phase: 2
Disease: Alopecia Areata, Alopecia Universalis, Alopecia Totalis
Location(s):
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.
A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses (SK-FAN)

A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses (SK-FAN)

Phase: 4
Disease: Seborrheic Keratosis
Location(s): Pennsylvania, Tennessee, Texas
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.
A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra

A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra

Phase: 2
Disease: Dermatosis Papulosa Nigra
Location(s): District of Columbia, New York
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.

Recruiting clinical trials

THWART-1 A Study of A-101 Topical Solution for the Treatment of Common Warts

THWART-1 A Study of A-101 Topical Solution for the Treatment of Common Warts

Phase: 3
Disease: Common Wart
Location(s):
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.
THWART-2 A Study of A-101 Topical Solution for the Treatment of Common Warts

THWART-2 A Study of A-101 Topical Solution for the Treatment of Common Warts

Phase: 3
Disease: Common Wart
Location(s):
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

Phase: 2
Disease: Atopic Dermatitis
Location(s):
Find out more at ClinicalTrials.gov »

Request more information about this clinical trial.

All fields required.

Thank you

We’re pleased you’d like to learn more about our clinical trials. Please look for an email from us with more information.